Search Results - reagents%2c+biomaterials%2c+and+plasmids

5 Results Sort By:
Helper Plasmids for Rescue of Respiratory Syncytial Virus
ApplicationPlasmids rescuing recombinant syncytial virus for RSV research and vaccine development.Key BenefitsAllow expression and recombination in vero cells.Optimized for human codon bios to increase expression in mammalian cells.Market SummaryRespiratory syncytial virus (RSV) is the major cause of acute lower respiratory tract infections in infants...
Published: 2/13/2025   |   Inventor(s): Martin Moore
Keywords(s): Reagents, Biomaterials, and Plasmids
Category(s): TechPub Algolia > Vaccines, TechPub Algolia > Research Tools
Untagged RSV A2-line 19F Strain Generated from BAC-RSV Clone
ApplicationStrain of respiratory syncytial virus (RSV) for vaccine and therapeutic research and development.Key Benefits High titer RSV strain. Strain A2-line 19F recapitulates human RSV infection in mouse models making it useful for initial vaccine studies. Market SummaryRespiratory syncytial virus (RSV) is the leading cause of lower respiratory tract...
Published: 2/13/2025   |   Inventor(s): Martin Moore
Keywords(s): Reagents, Biomaterials, and Plasmids
Category(s): TechPub Algolia > Research Tools, TechPub Algolia > Vaccines
Respiratory syncytial virus (RSV) Reporter Plasmid for High Throughput Drug Screening
Application Bioluminescence reporter for high throughput respiratory syncytial virus (RSV) drug discovery. Key Benefits Simple luciferase readout marker indicates RSV replication activity. Market Summary RSV is a ubiquitous respiratory pathogen worldwide. It is the most common cause of severe lower respiratory tract disease among infants and young...
Published: 2/13/2025   |   Inventor(s): Martin Moore, Anne Hotard (Lopez-Ona), Richard Plemper
Keywords(s): Reagents, Biomaterials, and Plasmids
Category(s): TechPub Algolia > Research Tools, TechPub Algolia > Drug Discovery, TechPub Algolia > Vaccines
Respiratory Syncytial Virus (RSV) Luminescent Reporter Strain
Application Modified respiratory syncytial virus (RSV) expressing a bioluminescent reporter protein for high throughput screening, vaccine development, and drug discovery. Plasmid encoding virus also available. Key Benefits Provides a new high throughput screening tool for RSV vaccine development and drug discovery. Bioluminescent assays outperform...
Published: 2/13/2025   |   Inventor(s): Richard Plemper, Martin Moore
Keywords(s): Reagents, Biomaterials, and Plasmids
Category(s): TechPub Algolia > Research Tools, TechPub Algolia > Vaccines
Respiratory Syncytial Virus (RSV) Fluorescent Reporter Strain
Application Modified RSV incorporating a red fluorescent reporter protein for vaccine, drug and biologic research & development. Key Benefits Provides new and needed screening tool for RSV research. Fluorescent protein included has better in vivo imaging capabilities than other more commonly used fluorescent proteins. Market Summary RSV...
Published: 2/13/2025   |   Inventor(s): Martin Moore, Anne Hotard (Lopez-Ona)
Keywords(s): Reagents, Biomaterials, and Plasmids
Category(s): TechPub Algolia > Research Tools, TechPub Algolia > Vaccines